Displaying 1 - 50 of 96 results
Released Company Title Industry Topic
21 Mar 2024
09:15 CET
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: CEO resignation 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Mar 2024
09:15 CET
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: Notice of annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Mar 2024
08:30 CET
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics: Annual report 2023 20103010 Biotechnology Annual financial and audit Reports
13 Mar 2024
15:11 CET
GENTIAN DIAGNOSTICS ASA New KDIGO Guidelines recommends increased use of cystatin C 20103010 Biotechnology Non-regulatory press releases
09 Feb 2024
08:00 CET
GENTIAN DIAGNOSTICS ASA Fourth quarter and full year 2023 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
30 Jan 2024
14:04 CET
GENTIAN DIAGNOSTICS ASA Invitation to presentation of fourth quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Dec 2023
14:13 CET
GENTIAN DIAGNOSTICS ASA Disclosure of shareholding 20103010 Biotechnology Major shareholding notifications
18 Dec 2023
09:23 CET
GENTIAN DIAGNOSTICS ASA Resignation of board member 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Dec 2023
09:24 CET
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
11 Dec 2023
13:29 CET
GENTIAN DIAGNOSTIC Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
24 Nov 2023
10:07 CET
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
26 Oct 2023
08:00 CEST
GENTIAN DIAGNOSTICS ASA Third quarter 2023 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
18 Oct 2023
12:19 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of third quarter results 20103010 Biotechnology Non-regulatory press releases
29 Sep 2023
13:41 CEST
GENTIAN DIAGNOSTICS ASA Expanding product portfolio with turbidimetric Retinol-Binding Protein (RBP) immunoassay 20103010 Biotechnology Non-regulatory press releases
29 Aug 2023
13:55 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
24 Aug 2023
08:00 CEST
GENTIAN DIAGNOSTICS ASA Second quarter 2023 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
16 Aug 2023
09:34 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of second quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
15 Jun 2023
08:38 CEST
GENTIAN DIAGNOSTICS ASA Gentian acquires Getica for SEK 3.0 million 20103010 Biotechnology Non-regulatory press releases
10 May 2023
10:42 CEST
GENTIAN DIAGNOSTICS ASA Capital Markets Day at 12.30 CEST today 20103010 Biotechnology Non-regulatory press releases
08 May 2023
14:41 CEST
GENTIAN DIAGNOSTICS ASA Reminder: Invitation to Capital Markets Day 10 May 2023 20103010 Biotechnology Non-regulatory press releases
05 May 2023
17:25 CEST
GENTIAN DIAGNOSTICS ASA Disclosure of shareholdings – Holta Invest AS 20103010 Biotechnology Major shareholding notifications
05 May 2023
17:05 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
05 May 2023
07:30 CEST
GENTIAN DIAGNOSTICS ASA First quarter 2023 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
04 May 2023
11:18 CEST
GENTIAN DIAGNOSTICS ASA Minutes from Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Apr 2023
10:55 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of first quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Apr 2023
09:24 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics invites to Capital Markets Day 20103010 Biotechnology Non-regulatory press releases
12 Apr 2023
13:12 CEST
GENTIAN DIAGNOSTICS ASA Notice of annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
30 Mar 2023
16:48 CEST
GENTIAN DIAGNOSTICS ASA Annual report 2022 20103010 Biotechnology Annual financial and audit Reports
22 Mar 2023
13:52 CET
GENTIAN DIAGNOSTICS ASA Health economic model identifies GCAL® as a cost-effective biomarker 20103010 Biotechnology Non-regulatory press releases
17 Mar 2023
15:45 CET
GENTIAN DIAGNOSTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
16 Feb 2023
08:00 CET
GENTIAN DIAGNOSTICS ASA Fourth quarter and full year 2022 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
15 Feb 2023
13:24 CET
GENTIAN DIAGNOSTICS ASA New study addresses the use of plasma calprotectin in sepsis management 20103010 Biotechnology Non-regulatory press releases
10 Feb 2023
13:42 CET
GENTIAN DIAGNOSTICS ASA Invitation to presentation of fourth quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
15 Dec 2022
12:50 CET
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
14 Dec 2022
15:24 CET
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics appoints new CSO 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
13 Dec 2022
10:03 CET
GENTIAN DIAGNOSTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
05 Dec 2022
11:09 CET
GENTIAN DIAGNOSTICS ASA Patent granted for NT-proBNP in the U.S. 20103010 Biotechnology Non-regulatory press releases
27 Oct 2022
09:20 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics signs distribution agreement with a major diagnostic company for the GCAL® Calprotectin Immunoassay 20103010 Biotechnology Inside information
27 Oct 2022
08:15 CEST
GENTIAN DIAGNOSTICS ASA Third quarter 2022 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
27 Oct 2022
08:00 CEST
GENTIAN DIAGNOSTICS ASA Third quarter 2023 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
21 Oct 2022
10:41 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of third quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Sep 2022
11:00 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics obtains IVDR certification 20103010 Biotechnology Non-regulatory press releases
27 Sep 2022
08:30 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics presents at Redeye Diagnostics conference 20103010 Biotechnology Non-regulatory press releases
07 Sep 2022
08:06 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics presents at the Pareto Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
29 Aug 2022
15:57 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
26 Aug 2022
13:17 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Aug 2022
16:28 CEST
GENTIAN DIAGNOSTICS ASA Mandatory notification of trade 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Aug 2022
08:00 CEST
GENTIAN DIAGNOSTICS ASA Second quarter 2022 report 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
23 Aug 2022
13:05 CEST
GENTIAN DIAGNOSTICS ASA Gentian Diagnostics signs distribution agreement for Cystatin C 20103010 Biotechnology Non-regulatory press releases
18 Aug 2022
12:41 CEST
GENTIAN DIAGNOSTICS ASA Invitation to presentation of second quarter results 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State